FFCP PHASE2:Hg19::chr14:54863667..54863678,+
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p3@CDKN3 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_3_at_CDKN3_5end |
Coexpression cluster: | C3434_prostate_Reticulocytes_mucinous_epidermoid_testis_teratocarcinoma_chronic |
Association with transcript: | 0bp_to_ENST00000335183, NM_001130851, NM_005192, uc001xap.2, uc001xaq.2, uc001xar.2_5end |
EntrezGene: | CDKN3 |
HGNC: | 1791 |
UniProt: | Q16667 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p3@CDKN3 |
---|
0
2
4
6
8
10
12
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 9.20e-30 | 235 |
disease of cellular proliferation | 5.58e-28 | 239 |
hematologic cancer | 4.13e-18 | 51 |
immune system cancer | 4.13e-18 | 51 |
organ system cancer | 7.97e-17 | 137 |
leukemia | 1.77e-13 | 39 |
cell type cancer | 4.62e-12 | 143 |
carcinoma | 1.10e-10 | 106 |
myeloid leukemia | 1.52e-09 | 31 |
lymphoma | 3.11e-07 | 10 |
Showing 1 to 10 of 10 entries